Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Authors:

Abstract
No abstract available
Funding Information
  • Bristol-Myers Squibb (CA209-840)
  • AstraZeneca
  • National Cancer Institute

This publication has 22 references indexed in Scilit: